PREVALENCE OF HIGH-ACTIVITY OF CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) IN HYPOALPHALIPOPROTEINEMIA

被引：0
|
作者：
TATO, F [1 ]
VEGA, GL [1 ]
GRUNDY, SM [1 ]
机构：
[1] UNIV TEXAS,SW MED CTR,CTR HUMAN NUTR,DALLAS,TX 75230
来源：
CLINICAL RESEARCH | 1994年 / 42卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A198 / A198
页数：1
相关论文
共 50 条
  • [21] MECHANISM OF ENHANCEMENT OF CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) ACTIVITY BY LIPOPROTEIN-LIPASE (LPL)
    TALL, AR
    SAMMETT, D
    CIRCULATION, 1984, 70 (04) : 343 - 343
  • [22] Thyroid hormones increase HDL catabolism and plasma cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice
    Oliveira, HCF
    Berti, JA
    Amaral, MEC
    Boschero, AC
    Harada, LM
    Tall, AR
    ATHEROSCLEROSIS, 1999, 144 : 115 - 115
  • [23] Future of Cholesteryl Ester Transfer Protein (CETP) Inhibitors: A Pharmacological Perspective
    Mohammadpour, Amir Hooshang
    Akhlaghi, Fatemeh
    CLINICAL PHARMACOKINETICS, 2013, 52 (08) : 615 - 626
  • [24] BIOCHEMICAL BASIS OF CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) ACTIVITY DEFICIENCY IN 2 HYPERALPHALIPOPROTEINEMIC SUBJECTS
    MATSUZAWA, Y
    YAMASHITA, S
    SPRECHER, DL
    HARMONY, JAK
    SAKAI, N
    TARUI, S
    WETTERAU, JR
    ARTERIOSCLEROSIS, 1989, 9 (05): : A691 - A691
  • [25] Diphenylpyridylethanamine (DPPE) Derivatives as Cholesteryl Ester Transfer Protein (CETP) Inhibitors
    Harikrishnan, Lalgudi S.
    Finlay, Heather J.
    Qiao, Jennifer X.
    Kamau, Muthoni G.
    Jiang, Ji
    Wang, Tammy C.
    Li, James
    Cooper, Christopher B.
    Poss, Michael A.
    Adam, Leonard P.
    Taylor, David S.
    Chen, Alice Ye A.
    Yin, Xiaohong
    Sleph, Paul G.
    Yang, Richard Z.
    Sitkoff, Doree F.
    Galella, Michael A.
    Nirschl, David S.
    Van Kirk, Katy
    Miller, Arthur V.
    Huang, Christine S.
    Chang, Ming
    Chen, Xue-Qing
    Salvati, Mark E.
    Wexler, Ruth R.
    Lawrence, R. Michael
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (13) : 6162 - 6175
  • [26] Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
    Amand F. Schmidt
    Nicholas B. Hunt
    Maria Gordillo-Marañón
    Pimphen Charoen
    Fotios Drenos
    Mika Kivimaki
    Deborah A. Lawlor
    Claudia Giambartolomei
    Olia Papacosta
    Nishi Chaturvedi
    Joshua C. Bis
    Christopher J. O’Donnell
    Goya Wannamethee
    Andrew Wong
    Jackie F. Price
    Alun D. Hughes
    Tom R. Gaunt
    Nora Franceschini
    Dennis O. Mook-Kanamori
    Magdalena Zwierzyna
    Reecha Sofat
    Aroon D. Hingorani
    Chris Finan
    Nature Communications, 12
  • [27] Cholesteryl ester transfer protein (CETP) gene and cholesterol metabolism in dementia
    Fernandez-Novoa, L.
    Llovo, R.
    Seoane, S.
    Corzo, L.
    Cacabelos, R.
    NEW TRENDS IN ALZHEIMER AND PARKINSON RELATED DISORDERS: ADPD 2007, 2007, : 31 - +
  • [28] Cholesteryl Ester Transfer Protein (CETP) Inhibitors: Is There Life After Torcetrapib?
    Neeli, Hemanth
    Rader, Daniel J.
    CARDIOLOGY CLINICS, 2008, 26 (04) : 537 - +
  • [29] Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a Mendelian randomization analysis
    Schmidt, Amand F.
    Davidson, Michael H.
    Ditmarsch, Marc
    Kastelein, John J.
    Finan, Chris
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [30] Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a Mendelian randomization analysis
    Schmidt, A.
    Davidson, M. H.
    Ditmarsch, M.
    Kastelein, J. J.
    Finan, C.
    CARDIOVASCULAR RESEARCH, 2024, 120
12345